further minor update September 2024
Consumers should be especially wary if a seller: Offers the drug without a prescription or licensed supervision Labels the product research-grade, for research use only or not approved for human use Sells it in unusual forms such as drops, sprays or skin patches rather than injectables Encourages buyers to mix, reconstitute or split doses on their own Promotes the product to minors Fails to include clear safety warnings or usage instructions Operates from another country or sells unusually large quantities Urges customers to falsify their weight or health status to obtain the drug Consumers can report unsafe or deceptive weight-loss drug offers to the NMDOJ Consumer Protection Division at nmdoj.gov/get-help/submit-a-complaint
If it hasnt and youre exhibiting symptoms like fatigue, numbness, or anemia, ask if a B test is needed
Inform the Test Administrator About Your Prescription Before taking a drug test, it is a good idea to tell the person in charge of the test about your prescription
At home (primary storage) Place the tirzepatide pen or vial in the main body of your refrigerator, not in the door and not against the back wall
Given the increasing interest in the potential use of incretins in cardiovascular diseases, conducting randomized controlled trials in this direction is warranted